Related Experiment Video
Updated: Jul 9, 2025

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Bibliometric analysis of residual cardiovascular risk: trends and frontiers
Lin Wang1, Sutong Wang1, Chaoyuan Song1,2
1First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China.
Insights
This bibliometric study analyzes research on residual cardiovascular risk, identifying key trends and hotspots. Findings highlight the growing global focus on lipid-lowering and inflammation, guiding future research directions.
Area of Science:
- Cardiology
- Bibliometrics
- Public Health
Background:
- Residual cardiovascular risk remains a significant contributor to cardiovascular events.
- Despite advances, a comprehensive bibliometric analysis of this field was lacking.
- Understanding research trends is crucial for future advancements.
Purpose of the Study:
- To conduct a bibliometric analysis of residual cardiovascular risk research.
- To identify current research hotspots and emerging trends.
- To guide future basic and clinical research in this area.
Main Methods:
- Literature search of the Web of Science Core Collection database (September 28, 2022).
- Analysis using bibliometric tools: CiteSpace, VOSviewer, Bibliometrix (R package), and Excel.
- Inclusion of 1167 publications.
Main Results:
- Publication output is rapidly increasing, with the United States leading in research.
- Harvard Medical School is the top institution; Ridker PM and Boden WE are prominent researchers.
- Key research areas include complications, risk factors, and pharmacological prevention strategies.
Conclusions:
- Global attention to residual cardiovascular risk is increasing.
- Current research focuses on lipid-lowering, inflammation, and dual-pathway inhibition.
- International collaboration is essential for comprehensive management and evaluation.
Background:
The presence of residual cardiovascular risk is an important cause of cardiovascular events. Despite the significant advances in our understanding of residual cardiovascular risk, a comprehensive analysis through bibliometrics has not been performed to date. Our objective is to conduct bibliometric studies to analyze and visualize the current research hotspots and trends related to residual cardiovascular risk. This will aid in understanding the future directions of both basic and clinical research in this area.
Methods:
The literature was obtained from the Web of Science Core Collection database. The literature search date was September 28, 2022. Bibliometric indicators were analyzed using CiteSpace, VOSviewer, Bibliometrix (an R package), and Microsoft Excel.
Result:
A total of 1167 papers were included, and the number of publications is increasing rapidly in recent years. The United States and Harvard Medical School are the leading country and institution, respectively, in the study of residual cardiovascular risk. Ridker PM and Boden WE are outstanding investigators in this field. According to our research results, the New England Journal of Medicine is the most influential journal in the field of residual cardiovascular risk, whereas Atherosclerosis boasts the highest number of publications on this topic. Analysis of keywords and landmark literature identified current research hotspots including complications of residual cardiovascular risk, risk factors, and pharmacological prevention strategies.
Conclusion:
In recent times, global attention toward residual cardiovascular risk has significantly increased. Current research is focused on comprehensive lipid-lowering, residual inflammation risk, and dual-pathway inhibition strategies. Future efforts should emphasize strengthening international communication and cooperation to promote the comprehensive evaluation and management of residual cardiovascular risk.
More Related Videos
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
07:51Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Vascular Resistance
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...